Clinical Characteristics of Infants with Symptomatic Congenital and Postnatal Cytomegalovirus Infection-An 11-Year

Yu-Ning Chen1, Kai-Hsiang Hsu1,2,3, Chung-Guei Huang4,5

  • 1Division of Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33382, Taiwan.

PubMed

Insights

Cytomegalovirus (CMV) infection in infants presents differently based on congenital (cCMV) or postnatal (pCMV) acquisition. Congenital CMV is linked to prematurity, while postnatal CMV shows higher rates of hepatitis and jaundice.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Cytomegalovirus (CMV) infection is common in newborns, affecting 0.2%–2.4%.
  • Limited data exists on the demographic and clinical features of symptomatic infant CMV infections.
  • Distinguishing between congenital CMV (cCMV) and postnatal CMV (pCMV) is crucial for understanding disease presentation.

Purpose of the Study:

  • To investigate the demographic characteristics, clinical presentations, and outcomes of infants with CMV infection.
  • To compare the features of congenital CMV (cCMV) versus postnatal CMV (pCMV) in infants.
  • To identify disparities and differing symptoms between cCMV and pCMV groups.

Main Methods:

  • Retrospective cohort study utilizing an 11-year multicenter database (2011–2021).
  • Included infants with confirmed CMV infection via urine culture, blood PCR, or IgM.
  • Analyzed clinical characteristics at diagnosis, management, and outcomes, differentiating between cCMV and pCMV.

Main Results:

  • 272 CMV-infected infants were analyzed; 21 had cCMV and 251 had pCMV.
  • Infants with cCMV showed higher rates of prematurity, being small for gestational age, and lower weight Z scores.
  • Thrombocytopenia was the primary symptom in cCMV, whereas hepatitis and prolonged jaundice were more common in pCMV.

Conclusions:

  • This study highlights distinct demographic and clinical profiles for congenital versus postnatal CMV infections in infants.
  • Findings underscore the need for tailored screening, treatment, and follow-up strategies for infants with CMV.
  • Further research is recommended to refine screening policies and management protocols for infant CMV.